A new review of data for Roche's flu drug Tamiflu has concluded the drug does not reduce hospitalisations and serious complications of the virus – and that it leads to harmful effects in patients.
The first generic of Roche’s flu antiviral Tamiflu has hit the US market. The privately-held generics firm Alvogen has developed the cut-price copy of Tamiflu (oseltamivir) with India’s Natco ...
Engineering microbes could be our best hope for creating enough antiviral drugs. As fears spread about a potential flu pandemic, Roche's antiviral drug Tamiflu (oseltamivir phosphate) has found ...
Patients might not know about Roche Tissue Diagnostics, but the Arizona entity has been testing for cancer and helping devise ...
Their lab experiments, published in March, found the two mutations appeared to raise H1N1's resistance to the flu treatment ...
Doctors frequently prescribe Tamiflu, an antiviral medication, to people who are at high risk of becoming seriously ill from the flu. The drug can ease symptoms and help people recover a bit faster.
Furthermore, strategic collaborations between major pharmaceutical players, such as Sanofi and Roche, are enhancing distribution networks and expanding the market reach of Tamiflu. Influenza ...
In 2006, during fears of a bird flu outbreak, the UK spent £473million stockpiling Tamiflu, an antiviral drug touted as a game-changer. However, it was later claimed its manufacturer, Roche ...
HK inno.N markets Roches Avastin for cancer treatment in South Korea HK inno.N and Roche forge collaboration to boost cancer ...